Company Filing History:
Years Active: 2025
Title: Innovations of Peter A Bullock in Immunology
Introduction
Peter A Bullock is a notable inventor based in Medford, MA (US). He has made significant contributions to the field of immunology, particularly through his innovative work on PD-1 binding proteins. His research focuses on developing immunoglobulin polypeptides that have the potential to impact cancer and autoimmune disease treatments.
Latest Patents
Peter A Bullock holds a patent for "Anti-PD-1 immunoglobulin polypeptides and uses thereof." This patent describes PD-1 binding proteins that comprise immunoglobulin domains specifically designed to bind to PD-1. The proteins include at least three or six specific complementarity determining regions (CDRs) and feature specific characteristics in their variable domain framework regions. The patent outlines various applications for these proteins, including their use as immunologic adjuvants, diagnostic tools, and therapeutic agents for disorders involving PD-1 expressing cells.
Career Highlights
Peter A Bullock is associated with Tufts College, where he continues to advance his research in immunology. His work has garnered attention for its potential to improve patient outcomes in therapies targeting PD-1 related conditions. With a focus on enhancing the stability and solubility of antigen binding proteins, Bullock's contributions are paving the way for innovative treatment options.
Collaborations
Due to space constraints, the details of collaborations will not be included.
Conclusion
Peter A Bullock's innovative work in the field of immunology, particularly with his patent on PD-1 binding proteins, showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of various diseases, highlighting the importance of innovation in healthcare.